Gen-Probe Inc. (NSDQ:GPRO) bought Waukesha, Wis.-based GTI Diagnostics in a self-funded $53 million cash deal. The acquisition allows the San Diego-based company to expand its transplant diagnostics ...

NEW YORK, July 30 (Reuters) - Gen-Probe Inc reported second-quarter net profit fell 20 percent on the impact of a stronger dollar and acquisition costs, and it lowered the top-end of its full-year ...

Diagnostic products maker Gen-Probe Inc. (:GPRO) has secured the approval of the U.S. Food and Drug Administration ("FDA") for its PROGENSA PCA3 assay, a novel molecular test designed to aid the ...

BOSTON (CBS.MW) -- Biotechnology stocks gained ground Friday, with shares of Gen-Probe among the upside standouts after the small biotech firm said it filed for regulatory approval for a new system to ...

announced today that the Company has acquired GTI Diagnostics, a privately held specialty diagnostics company focused on the transplantation, blood bank and specialty coagulation markets, for $53 ...